Table 1. Change of feed intake in SHR fed with experimental diets (g/rat) for 10 wk

Variable 1 2 3 4 5 6 7 8 9 10
NG 38.8±2.5NSa 36.5±2.3NSa 36.4±2.4NSa 37.3±2.9NSa 38.4±1.9NSa 38.2±2.3NSa 38.5±2.0Ba 38.9±2.1NSa 38.3±2.3NSa 39.0±3.5NSa
NCG 39.0±1.2abc 38.6±1.0abc 37.5±1.1c 38.0±0.8bc 39.6±1.3ab 40.1±2.0a 40.7±1.7ABa 38.8±1.1abc 40.6±1.2a 39.3±0.9abc
PCG 40.2±1.4a 37.0±1.8b 38.0±1.6ab 37.7±1.0ab 38.9±1.7ab 38.7±1.1ab 39.9±1.9ABab 39.1±2.2ab 40.1±2.2a 39.0±2.1ab
LTG 40.7±1.9ab 38.6±2.5b 37.6±2.5b 38.2±1.8b 38.7±1.9b 40.3±2.2ab 42.8±2.9Aa 39.6±2.1ab 40.8±1.9ab 39.0±1.8b
MTG 39.6±2.1a 38.6±2.2a 37.6±1.6a 38.2±0.7a 38.2±0.9a 38.5±1.4a 39.2±1.7Ba 38.3±2.5a 39.5±2.8a 39.4±2.6a
HTG 40.2±1.4a 37.5±0.8b 37.5±0.9b 38.1±1.6ab 38.3±1.0ab 38.0±1.4b 37.9±1.0Bb 37.8±1.5b 38.8±0.7ab 38.1±2.3ab
All values are the mean±SD (n=4).
Values in the column are not significantly different (p<0.05).
In the same column are significantly different (p<0.05).
In the same row are significantly different (p<0.05).
SHR, spontaneously hypertensive rats; NG, normal group (WKY) with distilled water; NCG, negative control group (SHR) with distilled water; PCG, positive control group (SHR) with Enalapril; LTG, low treatment group (SHR); MTG, medium treatment group (SHR); HTG, high treatment group (SHR); WKY, Wistar-Kyoto rats.